Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc.（HOWL）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · HOWL · 截至 2026年6月9日
活动摘要
买入笔数
3
P-Purchase only
卖出笔数
145
近12个月
买卖比
0.02
Buy/Sell (by trades)
整体情绪
Werewolf Therapeutics, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
HOWL 季度内部人买卖趋势
HOWL 内幕交易卖出 · HOWL 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · HOWL CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
HOWL 高管卖出股份 · HOWL 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 4, 2026 | EVNIN LUKE Director | Sale | 20,072 | $9K | Form 4 |
| Jun 5, 2026 | EVNIN LUKE Director | Sale | 24,946 | $10K | Form 4 |
| Jun 8, 2026 | EVNIN LUKE Director | Sale | 60,547 | $24K | Form 4 |
| Jun 1, 2026 | EVNIN LUKE Director | Sale | 80,459 | $38K | Form 4 |
| Jun 2, 2026 | EVNIN LUKE Director | Sale | 29,595 | $13K | Form 4 |
| Jun 3, 2026 | EVNIN LUKE Director | Sale | 29,749 | $12K | Form 4 |
| May 27, 2026 | EVNIN LUKE Director | Sale | 80,852 | $39K | Form 4 |
| May 28, 2026 | EVNIN LUKE Director | Sale | 27,698 | $13K | Form 4 |
| May 29, 2026 | EVNIN LUKE Director | Sale | 32,556 | $15K | Form 4 |
| May 21, 2026 | EVNIN LUKE Director | Sale | 36,387 | $15K | Form 4 |
| May 22, 2026 | EVNIN LUKE Director | Sale | 87,425 | $39K | Form 4 |
| May 26, 2026 | EVNIN LUKE Director | Sale | 67,950 | $32K | Form 4 |
| May 18, 2026 | EVNIN LUKE Director | Sale | 22,184 | $11K | Form 4 |
| May 19, 2026 | EVNIN LUKE Director | Sale | 62,970 | $28K | Form 4 |
| May 20, 2026 | EVNIN LUKE Director | Sale | 85,895 | $37K | Form 4 |
| May 13, 2026 | EVNIN LUKE Director | Sale | 44,679 | $24K | Form 4 |
| May 8, 2026 | EVNIN LUKE Director | Sale | 305,741 | $214K | Form 4 |
| May 11, 2026 | EVNIN LUKE Director | Sale | 33,948 | $23K | Form 4 |
| May 12, 2026 | EVNIN LUKE Director | Sale | 67,885 | $43K | Form 4 |
| May 8, 2026 | RA CAPITAL MANAGEMENT, L.P. 10 percent owner | Sale | 351,514 | $250K | Form 4 |
| May 11, 2026 | RA CAPITAL MANAGEMENT, L.P. 10 percent owner | Sale | 81,678 | $55K | Form 4 |
| May 12, 2026 | RA CAPITAL MANAGEMENT, L.P. 10 percent owner | Sale | 94,432 | $60K | Form 4 |
| May 8, 2026 | RA CAPITAL MANAGEMENT, L.P. 10 percent owner | Sale | 25,012 | $18K | Form 4 |
| May 11, 2026 | RA CAPITAL MANAGEMENT, L.P. 10 percent owner | Sale | 5,812 | $4K | Form 4 |
| May 12, 2026 | RA CAPITAL MANAGEMENT, L.P. 10 percent owner | Sale | 6,719 | $4K | Form 4 |
RA CAPITAL MANAGEMENT, L.P.
10 percent owner
日期
May 8
股数
351,514
均价
$0.71
总金额
$250K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 HOWL 内幕交易
HOWL 内幕交易
Werewolf Therapeutics, Inc.（HOWL）内幕交易数据来源于公司内部人（包括EVNIN LUKE (Director), MPM BioVentures 2014, L.P. (10% Owner), GADICKE ANSBERT (10% Owner)）提交的SEC Form 4申报文件。过去12个月内，4位内部人向SEC提交了交易申报。HOWL内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Werewolf Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
HOWL 内幕交易 · 5个问题Werewolf Therapeutics, Inc.（HOWL）的内部人包括高管和董事，如EVNIN LUKE (Director), MPM BioVentures 2014, L.P. (10% Owner), GADICKE ANSBERT (10% Owner)等。过去12个月内，4位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026